Kovacs K - Search Results

1

Temozolomide and Pituitary Tumors: Current Understanding, Unresolved Issues, and Future Directions.

Syro LV, Rotondo F, Camargo M, Ortiz LD, Serna CA, Kovacs K. Syro LV, et al. Among authors: kovacs k. Front Endocrinol (Lausanne). 2018 Jun 15;9:318. doi: 10.3389/fendo.2018.00318. eCollection 2018. Front Endocrinol (Lausanne). 2018. PMID: 29963012 Free PMC article. Review.

2

Temozolomide in aggressive pituitary adenomas and carcinomas.

Ortiz LD, Syro LV, Scheithauer BW, Rotondo F, Uribe H, Fadul CE, Horvath E, Kovacs K. Ortiz LD, et al. Among authors: kovacs k. Clinics (Sao Paulo). 2012;67 Suppl 1(Suppl 1):119-23. doi: 10.6061/clinics/2012(sup01)20. Clinics (Sao Paulo). 2012. PMID: 22584716 Free PMC article. Review.

3

Progress in the Diagnosis and Classification of Pituitary Adenomas.

Syro LV, Rotondo F, Ramirez A, Di Ieva A, Sav MA, Restrepo LM, Serna CA, Kovacs K. Syro LV, et al. Among authors: kovacs k. Front Endocrinol (Lausanne). 2015 Jun 12;6:97. doi: 10.3389/fendo.2015.00097. eCollection 2015. Front Endocrinol (Lausanne). 2015. PMID: 26124750 Free PMC article. Review.

4

65 YEARS OF THE DOUBLE HELIX: Treatment of pituitary tumors with temozolomide: an update.

Syro LV, Rotondo F, Ortiz LD, Kovacs K. Syro LV, et al. Among authors: kovacs k. Endocr Relat Cancer. 2018 Aug;25(8):T159-T169. doi: 10.1530/ERC-18-0015. Epub 2018 Mar 13. Endocr Relat Cancer. 2018. PMID: 29535142 Review.

5

Temozolomide therapy in a man with an aggressive prolactin-secreting pituitary neoplasm: Morphological findings.

Kovacs K, Horvath E, Syro LV, Uribe H, Penagos LC, Ortiz LD, Fadul CE. Kovacs K, et al. Hum Pathol. 2007 Jan;38(1):185-9. doi: 10.1016/j.humpath.2006.07.014. Epub 2006 Oct 23. Hum Pathol. 2007. PMID: 17056093

6

Role of MGMT in tumor development, progression, diagnosis, treatment and prognosis.

Sharma S, Salehi F, Scheithauer BW, Rotondo F, Syro LV, Kovacs K. Sharma S, et al. Among authors: kovacs k. Anticancer Res. 2009 Oct;29(10):3759-68. Anticancer Res. 2009. PMID: 19846906 Free article. Review.

7

Effect of temozolomide in a patient with recurring oncocytic gonadotrophic pituitary adenoma.

Syro LV, Scheithauer BW, Ortiz LD, Fadul CE, Horvath E, Rotondo F, Kovacs K. Syro LV, et al. Among authors: kovacs k. Hormones (Athens). 2009 Oct-Dec;8(4):303-6. doi: 10.14310/horm.2002.1247. Hormones (Athens). 2009. PMID: 20045804 Free article.

8

Treatment of pituitary neoplasms with temozolomide: a review.

Syro LV, Ortiz LD, Scheithauer BW, Lloyd R, Lau Q, Gonzalez R, Uribe H, Cusimano M, Kovacs K, Horvath E. Syro LV, et al. Among authors: kovacs k. Cancer. 2011 Feb 1;117(3):454-62. doi: 10.1002/cncr.25413. Epub 2010 Sep 15. Cancer. 2011. PMID: 20845485 Free article. Review.

9

MicroRNAs in the human pituitary.

Sivapragasam M, Rotondo F, Lloyd RV, Scheithauer BW, Cusimano M, Syro LV, Kovacs K. Sivapragasam M, et al. Among authors: kovacs k. Endocr Pathol. 2011 Sep;22(3):134-43. doi: 10.1007/s12022-011-9167-6. Endocr Pathol. 2011. PMID: 21647843 Review.

10

Anti-VEGF therapy in pituitary carcinoma.

Ortiz LD, Syro LV, Scheithauer BW, Ersen A, Uribe H, Fadul CE, Rotondo F, Horvath E, Kovacs K. Ortiz LD, et al. Among authors: kovacs k. Pituitary. 2012 Sep;15(3):445-9. doi: 10.1007/s11102-011-0346-8. Pituitary. 2012. PMID: 21918831

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,237 results

Search Page